Novartis Aktie
98,83
EUR
±0,00
EUR
±0,00
%
92,29
CHF
-1,05
CHF
-1,12
%
Kursziele der Novartis-Aktie in CHF
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Novartis-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| DZ BANK | - | - | 18.07.2025 | |
| Goldman Sachs Group Inc. | 95,00 CHF | +2,94% | 18.07.2025 | |
| Deutsche Bank AG | 115,00 CHF | +24,61% | 18.07.2025 | |
| JP Morgan Chase & Co. | 95,00 CHF | +2,94% | 18.07.2025 | |
| Bernstein Research | 115,00 CHF | +24,61% | 17.07.2025 | |
| Jefferies & Company Inc. | 100,00 CHF | +8,35% | 17.07.2025 | |
| UBS AG | 104,00 CHF | +12,69% | 17.07.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 89,00 CHF | -3,56% | 12.06.2025 | |
| Barclays Capital | 85,00 CHF | -7,90% | 21.11.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 0 | 136,58 GBP | +32,68% |
| Bayer | 2 | 7 | 0 | 26,86 EUR | -3,12% |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,80 EUR | +31,16% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,33 GBP | +21,14% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 163,50 EUR | +47,36% |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +8,08% |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +19,21% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 274,38 CHF | +6,14% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 113,12 EUR | +35,62% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |